5-bromo-N-((1-(cyclopropylsulfonyl)piperidin-4-yl)methyl)nicotinamide

Modify Date: 2025-08-27 15:23:53

5-bromo-N-((1-(cyclopropylsulfonyl)piperidin-4-yl)methyl)nicotinamide structure
Common Name 5-bromo-N-((1-(cyclopropylsulfonyl)piperidin-4-yl)methyl)nicotinamide
CAS Number 1797617-27-6 Molecular Weight 402.3
Density N/A Boiling Point N/A
Molecular Formula C15H20BrN3O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 5-bromo-N-((1-(cyclopropylsulfonyl)piperidin-4-yl)methyl)nicotinamide

 Chemical & Physical Properties

Molecular Formula C15H20BrN3O3S
Molecular Weight 402.3

 Preparation

O=C(NCC1CCN(S(=O)(=O)C2CC2)CC1)c1cncc(Br)c1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
Butanoic acid, 3,3-dimethyl-, 6,7a-dihydro-4-[(3-hydroxy-3-methyl-1-oxobutoxy)methyl]-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2a(2)-oxiran]-6-yl ester, [1S-(1I+/-,6I+/-,7I(2),7aI+/-)]-
137088-15-4
4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-7-oxo-3-(tetrahydro-2-furanyl)-, 2-propenyl ester, [5S-[3(S*),5I+/-,6I+/-(S*)]]-
182076-85-3
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-bromo-3,3-dimethyl-7-oxo-6-[1-[[(2,2,2-trichloroethoxy)carbonyl]oxy]ethyl]-, 2,2,2-trichloroethyl ester, [2S-[2I+/-,5I+/-,6I+/-,6(S*)]]-
98510-53-3
1,2-Piperidinedicarboxylic acid, 5-[(phenylmethoxy)amino]-, 1-(1,1-dimethylethyl) 2-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl] ester, (2S,5R)-
1690348-43-6
3-[6-(1,3a,4,6,10,10a-Hexahydro-6-oxopyrrolo[3,4-b]quinolizin-2(3H)-yl)-3,4-dihydro-4-oxo-1,3,5-triazin-2-yl]-1,2,3,4,5,6-hexahydro-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one
14603-31-7
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, [4S-(4I+/-,4aI+/-,5I+/-,5aI+/-,6I(2),12aI+/-)]-
18409-41-1
4-[2-Methoxy-5-[[(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-8-[(1,2,3,4-tetrahydro-6-methoxy-2-methyl-1-oxo-8-isoquinolinyl)oxy]-1-isoquinolinyl]methyl]phenoxy]benzaldehyde
172924-26-4
Pentanamide, 2-(dimethylamino)-4-methyl-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-, [3R-[3R*,4S*(S*),7S*]]-
19646-14-1
Spiro[7H-benz[e]indene-7,2a(2)-[1,3]dioxolane]-2-acetic acid, dodecahydro-3a-methyl-6-[2-(2-methyl-1,3-dioxolan-2-yl)ethyl]-I+/-,3-dioxo-, ethyl ester, [2S-(2I+/-,3aI+/-,5aI(2),6I(2),9aI+/-,9bI(2))]-
72877-77-1
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[2-[4-bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-oxopropyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1044275-81-1